GB202408056D0 - Anticoagulant protein molecules and uses thereof - Google Patents
Anticoagulant protein molecules and uses thereofInfo
- Publication number
- GB202408056D0 GB202408056D0 GBGB2408056.6A GB202408056A GB202408056D0 GB 202408056 D0 GB202408056 D0 GB 202408056D0 GB 202408056 A GB202408056 A GB 202408056A GB 202408056 D0 GB202408056 D0 GB 202408056D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- protein molecules
- anticoagulant protein
- anticoagulant
- molecules
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6432—Coagulation factor Xa (3.4.21.6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
- C12N9/6418—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals from snakes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21006—Coagulation factor Xa (3.4.21.6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2408056.6A GB202408056D0 (en) | 2024-06-06 | 2024-06-06 | Anticoagulant protein molecules and uses thereof |
| PCT/GB2025/051231 WO2025253121A1 (en) | 2024-06-06 | 2025-06-05 | Anticoagulant protein molecules and uses thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2408056.6A GB202408056D0 (en) | 2024-06-06 | 2024-06-06 | Anticoagulant protein molecules and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202408056D0 true GB202408056D0 (en) | 2024-07-24 |
Family
ID=91948580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2408056.6A Ceased GB202408056D0 (en) | 2024-06-06 | 2024-06-06 | Anticoagulant protein molecules and uses thereof |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB202408056D0 (en) |
| WO (1) | WO2025253121A1 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5278144A (en) * | 1990-09-04 | 1994-01-11 | Cor Therapeutics, Inc. | Antithrombosis agents |
| CA2949349A1 (en) * | 2014-05-26 | 2015-12-03 | Academisch Ziekenhuis Leiden | Prohemostatic proteins for the treatment of bleeding |
| CA3002250C (en) * | 2014-10-23 | 2024-02-06 | Q-Sera Pty Ltd | Improved clotting composition |
| EP3830135A1 (en) * | 2018-08-01 | 2021-06-09 | Novo Nordisk A/S | Improved procoagulant antibodies |
-
2024
- 2024-06-06 GB GBGB2408056.6A patent/GB202408056D0/en not_active Ceased
-
2025
- 2025-06-05 WO PCT/GB2025/051231 patent/WO2025253121A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025253121A1 (en) | 2025-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4159757A4 (en) | Sars-cov-2 spike protein binding molecule and application thereof | |
| EP4119162A4 (en) | Pvrig binding protein and its medical uses | |
| EP4185614A4 (en) | SARS-COV-2 ANTIGEN-RECOGNIZING BINDING PROTEINS AND USES THEREOF | |
| BRPI0620125A8 (en) | method for regulating reduction of biological function of a protein, unnaturally occurring molecule, recombinant vector, and method for isolating a protein from a sample | |
| EP4157888A4 (en) | MODIFIED PROTEINS AND PROTEIN DEGRADERS | |
| DE602005012555D1 (en) | Artificial protein for the absolute quantification of proteins and uses thereof | |
| EP4279507A4 (en) | Cd73-binding protein and use thereof | |
| GB202408056D0 (en) | Anticoagulant protein molecules and uses thereof | |
| IL316176A (en) | Siglec-8 binding proteins and uses thereof | |
| IL324646A (en) | Protein particles comprising beta-lactoglobulin and uses thereof | |
| IL318460A (en) | Rabies g protein and uses thereof | |
| IL311185A (en) | Mog-binding proteins and uses thereof | |
| DE60326494D1 (en) | MANNOSYL (1-2) GLYCOSYL (1-2) GLYCERATE FOR STABILIZING AND PRESERVING BIOMATERIALS | |
| AU2024903363A0 (en) | Proteins and uses thereof | |
| IL324416A (en) | Iinsecticidal protein and use thereof | |
| AU2024903366A0 (en) | Proteins and uses thereof - II | |
| CA3287113A1 (en) | Trop2-binding proteins and uses thereof | |
| CA3284229A1 (en) | Multivalent anti-spike protein binding molecules and uses thereof | |
| CA3284228A1 (en) | Multivalent anti-spike protein binding molecules and uses thereof | |
| AU2024229213A1 (en) | Multivalent anti-spike protein binding molecules and uses thereof | |
| AU2024904221A0 (en) | Proteinaceous molecules and uses therefor | |
| AU2024903147A0 (en) | Proteinaceous molecules and uses therefor | |
| EP4416282A4 (en) | PROTEIN MOLECULES AND THEIR USES | |
| HK40120368A (en) | Anti-idiotype antibody molecules and uses thereof | |
| AU2024319932A1 (en) | Btn3a-binding protein and medical uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |